Modulating effects of olanzapine on the development of diabetic ketoacidosis.
N
N
Tsuchiyama
H
H
Ando
T
T
Ota
M
M
Sakurai
T
T
Takamura
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D000077152:Olanzapine
D014150:Antipsychotic Agents; D007328:Insulin; D001569:Benzodiazepines; D000077152:Olanzapine